Not finding it? Sign in to also search OpenAlex live.
-
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2–20 years) with type 1 diabetes: a population-based study2024 The Lancet Diabetes & Endocrinology article Medicine Diabetes Management and Research Open access
Beate Karges, Joachim Rosenbauer, Anna Stahl‐Pehe, Monika Flury, Torben Biester, Martin Tauschmann, +3 more
46citations -
ESE audit on management of adult growth hormone deficiency in clinical practice2020 European Journal of Endocrinology article Medicine Growth Hormone and Insulin-like Growth Factors Open access
Luciana Martel‐Duguech, Jens Otto Lunde Jørgensen, Márta Korbonits, Gudmundur Johannsson, Susan M. Webb, Fotini Adamidou, +43 more
27citations -
Diagnosis and management of Silver–Russell syndrome: second international consensus statement2026 Nature Reviews Endocrinology review Biochemistry, Genetics and Molecular Biology Genetic Syndromes and Imprinting Open access
Emma Wakeling, Justin H. Davies, Éloïse Giabicani, Susan M. O'Connell, Madeleine D. Harbison, Amélie Perrière, +33 more
0citations -
Unterschiede in HbA1c-senkender Wirkung und Hypoglykämierisiko zwischen Insulin glargin 300 E/ml (Gla-300) und Insulin degludec 100 E/ml (IDeg) je nach Nierenfunktion in der BRIGHT-Studie
Martin Haluzı́k, Athena Philis‐Tsimikas, Zsolt Bosnyák, Dirk Müller‐Wieland, Felipe Lauand, Lydie Melas‐Melt, +2 more
0citations -
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial
Martin Haluzı́k, ALICE Y.Y. CHENG, Dirk Müller‐Wieland, Jukka Westerbacka, Zsolt Bosnyák, Felipe Lauand, +4 more
31citations -
Unterschiede bei der HbA1c-Senkung zwischen Insulin glargin 300 E / ml (Gla-300) und Insulin degludec 100 E / ml (IDeg-100) bei Typ-2-Diabetespatienten ≥ 70 Jahre in der BRIGHT-Studie
Dirk Müller‐Wieland, Bernard H. Charbonnel, V.R. Aroda, J Westerbakka, Felipe Lauand, Emmanuelle Boëlle, +3 more
0citations -
Glycaemic control in people with type 2 diabetes (T2D) switching from NPH to insulin glargine 300 U/mL (Gla-300): REALI pooled database2022 HAL (Le Centre pour la Communication Scientifique Directe) conference-paper Medicine Diabetes Treatment and Management
D. Mueller‐Wieland, Nick Freemantle, Riccardo C. Bonadonna, Celine Mauquoi, Grégory Bigot, Mireille Bonnemaire, +2 more
0citations -
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project
Nick Freemantle, Riccardo C. Bonadonna, Pierre Gourdy, Dı́dac Mauricio, D. Mueller‐Wieland, Grégory Bigot, +4 more
11citations -
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Pierre Gourdy, Riccardo C. Bonadonna, Nick Freemantle, Dı́dac Mauricio, Dirk Müller‐Wieland, Grégory Bigot, +3 more
6citations -
Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia2023 American Journal of Kidney Diseases article Medicine Diabetes Treatment and Management Open access
Thomas Ebert, Marni Greig, Claudia Lamina, Marc Froissart, Kai‐Uwe Eckardt, Jürgen Floege, +4 more
6citations -
Sociodemographic and biological determinants of insulin initiation in type 2 diabetes: a cohort study using routinely collected primary care data2025 British Journal of General Practice article Medicine Diabetes Treatment and Management Open access
Sukainah Alfaraj, Rimke Cathelijne Vos, Marco René Spruit, Rolf H. H. Groenwold, Dennis Owen Mook-Kanamori
0citations -
Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years2020 BMJ Open Diabetes Research & Care article Medicine Diabetes Treatment and Management Open access
Rimke Cathelijne Vos, Henk den Ouden, Lois A. Daamen, Henk J.G. Bilo, Petra Denig, Guy E.H.M. Rutten
4citations